COPENHAGEN, Denmark, Sept. 29, 2026 -- Breye Therapeutics ApS (Breye), a clinical-stage biopharmaceutical company developing oral therapeutics for the early treatment of retinal diseases, today announced the successful close of...
Arthur Klausner will sit on a panel at the 11th Annual Drug Delivery Technologies and Deal Making Conference, sponsored by SRI
News | 09. 26. 2006
